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A commentary on
Conditional Steroidogenic Cell-Targeted Deletion of TSPO Unveils a Crucial Role in Viability 
and Hormone-Dependent Steroid Formation
by Fan J, Campioli E, Midzak A, Culty M, Papadopoulos V. Proc. Natl. Acad. Sci. U S A (2015) 
112:7261–7266. doi: 10.1073/pnas.1502670112
Recent reports on Leydig cell-specific Tspo conditional knockout TspocΔ/Δ mice (1), viable global 
Tspo knockout (Tspo−/−) mice from two independent laboratories (2, 3), and clones of CRISPR/Cas9-
mediated Tspo-deleted MA-10 Leydig cells (MA-10TspoΔ/Δ) (4) established that TSPO is not essential 
for steroid hormone biosynthesis or viability [reviewed in Ref. (5, 6)]. These reports refuted 25 years 
of dogma that described TSPO as a mitochondrial cholesterol transport protein, indispensable for 
steroidogenesis. In response, the research group involved in most of the early studies linking TSPO 
and steroidogenesis investigated Leydig cell-specific and adrenocortical cell-specific TspocΔ/Δ mice 
(7) and presented results that seem to repudiate the recent findings and revive the old model. In this 
commentary, we would like to point out that interpretations made in the manuscript by Fan et al. 
(7) are seriously flawed.
tSPo DeletIon DoeS not aFFeCt VIaBIlIty
In Fan et al. (7), it was observed that use of Amhr2cre/+ knock-in mice (8) to generate Leydig cell-
specific TspocΔ/Δ mice resulted in low Mendelian ratios for homozygous cre positive mice (HO: 
Amhr2cre/+TspocΔ/Δ). This was interpreted as partial preimplantation embryo loss, and the authors 
concluded that TSPO is crucial for viability. This is a fundamental mistake because both Amhr2 
and Tspo are in the same chromosome 15 and, therefore, cannot assort independently. The Tspo and 
Amhr2 genetic positions are just 18.18 cM apart, and the probability for chromosomal crossover 
between the two loci to get HO mice is calculated as 7.6% [based on Haldane (9), other estimates 
are similar]. Therefore, the low rate of 4.4% HO mice observed by Fan et al. (7) is anticipated and 
represents the precise biological value due to linkage of the two loci and is certainly not an indica-
tion of embryonic lethality (Figure 1) [Note: Actual values are not identical to calculated numbers 
FIGUre 1 | “embryonic lethality” based on a miscalculation: 
inheritance of the Tspo and Amhr2 gene loci in chromosome 15 with 
respective floxed and knock-in cre alleles. Murine chromosome 15 
showing the physical positions (in megabases – Mb) and genetic positions (in 
centimorgans – cM) of Tspo and Amhr2 genes (drawn to scale). F1: breeding 
between Tspofl/flAmhr2+/+ and Tspo+/+Amhr2Cre/+ can produce cre positive 
heterozygous Tspofl/+Amhr2Cre/+ (HE) offspring and Tspofl/+Amhr2+/+ offspring 
(not shown). With tissue-specific cre drivers, there is recombination in cre 
expressing cells leading to Tspo−/+Amhr2Cre/+ HE mono-allelic knockout cells. 
F2: HE mice are backcrossed with Tspofl/flAmhr2+/+ mice in order to generate 
Tspofl/fl, Amhr2Cre/+ (HO) mice. The Tspofl/flAmhr2+/+ mice produce only one 
gamete genotype, whereas HE mice produce four gamete genotypes, the 
ratio of which depends on the frequency of odd number of crossovers that 
occur between the Tspo and Amhr2 loci, and not through independent 
assortment, because they are in the same chromosome. Consequently, the 
gamete genotype necessary for generating HO offspring occurs at a 
calculated frequency of 7.6%. This is much lower than the classic Mendelian 
ratio of 25% because Tspo and Amhr2 gene loci are closely spaced in 
chromosome 15, and are, therefore, linked and inherited together at a high 
frequency. The experimental value of 4.4% observed by Fan et al. (7), is 
anticipated and indicates the biological value for that particular mouse strain. 
Therefore, interpretation of embryonic lethality in HO mice based on an 
incorrect expectation of 25% by Fan et al. (7) is seriously flawed.
(Continued)
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because of differences in mouse strain, secondary regulation, 
specific chromosome structures, and interference at crossover 
sites]. Expectation of 25% HO mice based on classical Mendelian 
principles is not applicable in this context, and the interpretation 
made on this basis is highly inaccurate.
To explain their proposed case of embryonic lethality, Fan 
et  al. (7) proposed that the Amhr2cre/+ knock-in mice used to 
generate gonadal cell type-specific conditional deletions in more 
than 90 publications (MGI ID: 3042214), in their particular case, 
could induce global Tspo deletions. The justification provided 
was published microarray datasets that seemed to detect (with 
inconsistencies) an increase in Amhr2 transcription in 2-cell 
embryos. There was no primary data in the manuscript validat-
ing this assertion that appears highly unlikely. Even if it were to 
occur, global Tspo deletions would not affect the linkage and rate 
of HO mice as described above. In previous studies that used cre 
on different chromosomes, Mendelian ratios were observed dur-
ing generation of viable global Tspo−/− mice with similar mouse 
backgrounds (2, 3).
tSPo IS not InVolVeD In 
SteroIDoGeneSIS
In Fan et al. (7), the Nr5a1creTspocΔ/Δ mice showed expected Tspo 
deletions in Leydig cells and the adrenal cortex. Testosterone 
production (both baseline and after induction using hCG) was 
not affected, consistent with the previous report (1). Although the 
authors note this as “surprising,” the significance of this observa-
tion as indication that TSPO was not involved in mitochondrial 
cholesterol import in Leydig cells was disregarded. It is not our 
intention to criticize, but we are indeed under obligation to 
point out that the proclaimed landmark in vitro studies of Tspo 
disruption (10) and Tspo knockdown (11) used as foundations for 
asserting TSPO link to steroidogenesis were performed only using 
Leydig cells by this same research group. These in vitro results have 
since not been reproducible both in vitro (2, 4) and in vivo (1, 2) 
and is now also invalidated by Fan et al. (7) without an explanation.
In Nr5a1creTspocΔ/Δ mice, baseline corticosterone levels 
were also unaffected, consistent with the previous report (2). 
However, when induced with ACTH, circulating corticosterone 
did not increase in both heterozygous (TspocΔ/+) and homozygous 
(TspocΔ/Δ) deletions of Tspo compared to Tspofl/fl controls, an 
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observation that had no correlation to TSPO expression levels 
and was in contrast to the previous report (2). This inconsist-
ency and differences observed with regard to lipid accumulation 
and changes to Lhcgr and Scarb1 expression in Nr5a1creTspocΔ/Δ 
adrenals (7) may be linked to parallel findings showing that TSPO 
can affect lipid metabolism in cells (12). Although additional 
work is necessary, by attempting to provide explanations based 
on the unsubstantiated conjecture that TSPO is an essential 
cholesterol transport protein for steroidogenesis, the authors 
have missed an excellent opportunity to advance understanding 
of TSPO function.
ConClUDInG remarKS
Global Tspo−/− mice are viable (2, 3) and are an excellent 
tool for investigating TSPO function in health and disease. 
Evidence refuting TSPO link to steroidogenesis is not based 
only on reports in Tspo−/− mice (2, 3). Recent studies, using 
Tspo-deficient isolated mitochondria (3), in vitro Tspo knock-
down (2), and CRISPR/Cas9-mediated Tspo knockout in cell 
lines (4), have all highlighted problems with reproducibility 
of prior work. The serious misinterpretations made in Fan 
et  al. (7) are negatively impacting research progress across 
multiple fields and distracting from pursuit of the core func-
tion of TSPO.
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